SE9902674D0 - New composition - Google Patents

New composition

Info

Publication number
SE9902674D0
SE9902674D0 SE9902674A SE9902674A SE9902674D0 SE 9902674 D0 SE9902674 D0 SE 9902674D0 SE 9902674 A SE9902674 A SE 9902674A SE 9902674 A SE9902674 A SE 9902674A SE 9902674 D0 SE9902674 D0 SE 9902674D0
Authority
SE
Sweden
Prior art keywords
composition
new composition
kit
active ingredient
rofleponide
Prior art date
Application number
SE9902674A
Other languages
Swedish (sv)
Inventor
Gunilla Nygaard
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9902674A priority Critical patent/SE9902674D0/en
Publication of SE9902674D0 publication Critical patent/SE9902674D0/en
Priority to AU61943/00A priority patent/AU6194300A/en
Priority to PCT/SE2000/001469 priority patent/WO2001003703A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a composition or kit having as first active ingredient rofleponide, its esters and salts and as a second active ingredient an antibiotic, the use of the composition and kit in the treatment of intestinal conditions, especially Crohn's disease and processes for preparation of the composition.
SE9902674A 1999-07-12 1999-07-12 New composition SE9902674D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9902674A SE9902674D0 (en) 1999-07-12 1999-07-12 New composition
AU61943/00A AU6194300A (en) 1999-07-12 2000-07-07 An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease
PCT/SE2000/001469 WO2001003703A1 (en) 1999-07-12 2000-07-07 An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902674A SE9902674D0 (en) 1999-07-12 1999-07-12 New composition

Publications (1)

Publication Number Publication Date
SE9902674D0 true SE9902674D0 (en) 1999-07-12

Family

ID=20416478

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902674A SE9902674D0 (en) 1999-07-12 1999-07-12 New composition

Country Status (3)

Country Link
AU (1) AU6194300A (en)
SE (1) SE9902674D0 (en)
WO (1) WO2001003703A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704833D0 (en) * 1997-12-22 1997-12-22 Astra Ab New formulation

Also Published As

Publication number Publication date
AU6194300A (en) 2001-01-30
WO2001003703A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
WO2001092288A3 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
RS50814B (en) Tartarate salts of 5,8,14-triazatetracyclo(10.3.1.02,11.04,9 )-hexadeca-2(11)3,5,7,9-pentaene and pharmaceutical compositions thereof
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
EP1783126A3 (en) N-oxides of N-phenyl-2-pyrimidine-amine derivatives
GB9902555D0 (en) Medicament
WO2006034001A3 (en) Methods of treating hiv infection
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
BR0014560B1 (en) use of a tissue treatment composition.
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
HUP0304085A3 (en) The citrate salt of 5,8,14-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
NO20044549L (en) Bis-cyclic 6-alkalidene penes as beta-lactamase inhibitors
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
EE05241B1 (en) Use of the α-halogenoacryl derivative of distamycin
BR0309878A (en) Heterotricyclyl-6-alkylidene penenes as beta-lactamase inhibitors
SE0001916D0 (en) Novel formulation
UY27373A1 (en) BETA-HUMAN INTERFER FORMULATIONS
GR1003490B (en) Novel pharmaceutical compositions comprising a salt of paraxetine
EA200200853A1 (en) APPLICATION OF 2-METHYL THIAZOLIDINE-3,3-DICARBONIC ACID (2-MTDK) AND / OR ITS PHYSIOLOGICAL COMPATIBLE SALTS FOR THE TREATMENT AND / OR CANCER PREVENTION
HUP0204208A2 (en) Antipruritic agents for external use
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
SE9902674D0 (en) New composition
PT1052991E (en) USING LOPERAMID FOR THE TREATMENT OF MICROBIAL INFECTIONS
SE9902673D0 (en) New composition